URAC Disease Management Accreditation — How It Compares to Other Quality Credentials

Last updated: April 2026

Disease management organizations and health plans pursuing quality accreditation face a landscape of overlapping options: URAC Disease Management, NCQA Population Health, URAC Case Management, and the option of operating without third-party accreditation at all. This guide compares those paths — their scope, market recognition, practical requirements, and how to choose.

The Disease Management Accreditation Landscape

Until 2019, two major accrediting bodies maintained disease management-specific credentials: URAC and NCQA. NCQA retired its Disease Management Accreditation and Certification programs in November 2019, transitioning to Population Health Program Accreditation — a broader credential reflecting the market shift from single-condition DM toward whole-person population health management.

URAC continues to maintain active Disease Management Accreditation standards. This consolidation means URAC Disease Management Accreditation is now the primary DM-specific third-party credential in the healthcare market. Organizations that previously held or were considering NCQA DM credentials must decide whether to pursue URAC DM, NCQA's Population Health replacement, or both.

Comparison at a Glance

URAC Disease Management vs. NCQA Population Health Program Accreditation

These are the two most commonly compared options for chronic disease management quality validation. The distinction matters because they are structurally different credentials, not interchangeable alternatives.

URAC Disease Management Accreditation

URAC DM evaluates a defined disease management program model. Standards focus on how an organization identifies and stratifies its chronically ill population, communicates with and educates members, manages risk, engages consumers in self-management, and monitors quality outcomes. The program is disease-management specific — it speaks directly to the function and the market segment.

Health plan clients, commercial payers, and disease management vendor procurement processes frequently reference URAC Disease Management Accreditation as the applicable quality standard. The credential's specificity to the DM function is an advantage in contracting contexts that use DM-specific language.

NCQA Population Health Program Accreditation

NCQA's Population Health Program Accreditation replaced its retired Disease Management programs in 2019 and reflects the broader shift from single-condition DM toward whole-person population health. The credential evaluates person-centered care, data and analytics capabilities, care management processes, and quality improvement — with a framing more oriented toward integrated health systems and health plans pursuing comprehensive population health strategies.

NCQA's Population Health credential is recognized in health plan and Medicaid markets, particularly among organizations that were previously NCQA-accredited for DM and transitioned to the Population Health pathway.

Which to Choose

The right credential depends on three factors: your client base and their specific requirements, your market position (standalone DM vendor vs. integrated health system), and whether your operational model is better described as disease management or broader population health. Organizations selling DM services to commercial health plans frequently find URAC DM accreditation better aligned with client contract language. Organizations embedded in integrated delivery systems or government-program-dominant markets often find NCQA Population Health more appropriate. Some pursue both.

IHS advises on this determination as part of every initial consultation.

URAC Disease Management vs. URAC Case Management Accreditation

Both are URAC credentials, but they address fundamentally different operational functions.

Disease Management — Population Level

URAC Disease Management Accreditation evaluates how an organization manages a defined population of chronically ill members — identification, stratification, population-level communication, engagement tracking, and quality measurement across the cohort. The unit of analysis is the population.

Case Management — Individual Level

URAC Case Management Accreditation evaluates how an organization coordinates care for individual patients — comprehensive assessments including medication review, individualized care plans, progress monitoring, and documented case closure. The unit of analysis is the individual case.

When You Need Both

Many health plans, MCOs, and integrated health systems need both credentials. A health plan may run a DM program for all members with diabetes (population level) while also providing intensive case management for members with the most complex comorbid conditions (individual level). These are distinct functions requiring distinct operational infrastructure — and URAC evaluates them separately.

Pursuing both credentials simultaneously is operationally efficient because they share foundational standards (Risk Management, Operations and Infrastructure, Quality Management Infrastructure) that only need to be built once. IHS regularly manages coordinated multi-program accreditation engagements to maximize this efficiency.

URAC Disease Management Accreditation vs. Operating Without Accreditation

Disease management organizations that operate without third-party accreditation face three specific disadvantages that compound over time.

Contracting Disadvantage

Health plans, employer groups, and government programs increasingly include accreditation requirements or strong preferences in DM vendor RFPs. An unaccredited DM organization may be eliminated from consideration before the first conversation — regardless of the quality of its actual program. Accreditation converts quality claims from marketing language into independently verified evidence, which matters when procurement evaluators must compare competing vendors.

Regulatory Exposure

Some state and federal programs reference accreditation standards as benchmarks for DM program compliance. While accreditation itself may not be legally required in every market, operating in alignment with URAC standards reduces regulatory exposure and provides a defensible quality framework if program quality is challenged.

Internal Quality Gaps

The process of pursuing accreditation — gap analysis, policy development, look-back period discipline, mock survey — frequently surfaces operational problems that organizations did not know existed. Programs that go through accreditation consistently emerge with stronger quality infrastructure than when they started, independent of the credential itself. Organizations that never pursue accreditation forgo that structured quality development process.

The Counterargument — and Its Limits

Some organizations elect not to pursue accreditation because their current client base does not require it, or because they assess the cost and timeline as disproportionate to the return in their specific market. That is a legitimate business calculation. The risk is that market requirements can change — a single large client contract renewal can introduce an accreditation requirement that creates a compressed timeline problem. Organizations that have done preparatory work in advance are far better positioned to respond.

Why the Choice of Consulting Partner Matters as Much as the Choice of Credential

Choosing between URAC Disease Management and NCQA Population Health is a strategic decision. Executing the chosen credential successfully is an operational one. Both require expertise — and the two forms of expertise are different.

IHS brings a specific advantage to URAC Disease Management engagements: Thomas G. Goddard, JD, PhD served as former Chief Operating Officer and General Counsel of URAC before founding IHS. That is not a standard consulting background. It reflects direct institutional knowledge of how URAC standards are developed, how reviewers are trained to interpret them, and where the consistent failure points emerge across applicant organizations.

For NCQA-pathway decisions, IHS provides strategic advisory on the multi-body landscape and can advise on whether an NCQA Population Health engagement is the right path — and what that path requires — even if the execution is ultimately handled through NCQA's own resources or a specialist in that credential.

The starting point for either path is the same: an honest, standard-by-standard assessment of where your organization stands today.

Not Sure Which Credential Is Right for Your Organization?

The right accreditation strategy depends on your client mix, contract requirements, operational scope, and market positioning. IHS provides an initial consultation to assess these factors and give a clear recommendation — one path, with reasoning, not a menu of options to evaluate on your own.

Schedule a Free Discovery Session with Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — to discuss which accreditation path best fits your organization's situation.